Breast Cancer

OHSU researchers identified new drug combination that could overcome treatment resistance in acute myeloid leukemia

If 2024 was defined by the looming threat of the FDA's "Final Rule" on laboratory-developed tests (LDTs), 2025 was defined by its sudden dismantling

Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression

This is especially crucial for patients with treatment-resistant cancers and those with triple-negative breast cancer

Despite significant progress in recent years, it remains challenging to accurately identify the best treatments for individual patients and to predict cases with poorer prognosis

Clairity’s first FDA authorized AI platform for breast cancer prediction demonstrates consistent accuracy, real-world impact, and potential to transform global breast cancer screening

Targeted measures needed to boost attendance among initial non-attenders and reduce mortality risk, say researchers

The findings support further clinical studies to determine whether this marker may help identify patients who could benefit from CDK4/6 inhibitors

Study shows how tamoxifen may raise uterine cancer risk and points to a possible way to prevent it

New research shows COVID-19 and flu infections may awaken dormant breast cancer cells in lungs, increasing the risk of metastasis